Abstract:Neurofibrillary tangles (NFTs), consisting of aggregates of abnormally hyperphosphorylated tau, are indicated in the pathogenesis of several neurodegenerative diseases including Alzheimer's disease (AD). Although hyperphosphorylation of tau is thought to cause aggregation and dissociation of tau from microtubules, the molecular mechanisms underlying the regulation of tau phosphorylation are largely unknown. While the PI3K/Akt pathway has increasingly been shown to regulate multiple cellular events pertinent to AD pathogenesis, including β–amyloid metabolism and tau phosphorylation via GSK–3, potential functions of tumor suppressor PTEN in AD pathogenesis have not been explored. In our study, we explored the molecular mechanisms for regulation of tau phosphorylation by asking the question that if PTEN, a tumor suppressor in PI3K/Akt signaling pathway, can affect tau phosphorylation at Akt and GSK–3 phosphorylation sites and the consequential effects on tau aggregation and binding to microtubules. We examined the effects of PTEN on tau phosphorylation, its microtubule association and formation of aggregates. We cotransfected COS–7 cells with human tau and human wild–type or phosphatase activity null mutant PTEN. We evaluated PTEN's effects on tau phosphorylation by using phospho–tau specific antibodies. To assess PTEN's effects on tau aggregation and binding to microtubules, we performed filter–retardation assay to detect and compare tau aggregates in cultured cells in the presence of wild–type or mutant PTEN. In addition, we fractioned the cotransfected cells to detect and compare the cytosolic, microtubule–bound, membrane–bound and insoluble aggregated tau between cells expressing wild–type and the mutant PTEN. Moreover, we infected rat cortical primary neurons with Sindbis viruses expressing wild–type or the mutant PTEN to monitor neuronal growth. At last, we performed immunohistology to compare phospho–tau and PTEN levels between AD patient and non–AD brains. 1. PTEN affects tau phosphorylation at Akt and GSK–3 phosphorylation sites. 2. PTEN affects tau aggregation and binding to microtubules. 3. PTEN's effects on tau phosphorylation are partially through PIP3/Akt signaling pathway.

Phosphorylation of Tau by Glycogen Synthase Kinase 3β in Intact Mammalian Cells Influences the Stability of Microtubules

Defects in the autophagy lysosomal pathway in a cell model of disease‐associated tau

GLYCATION OF TAU PROTEIN PROMOTES THE FORMATION OF FILAMENTS DURING TAU PHOSPHORYLATION

Role of Microtubule-Associated Protein Tau Phosphorylation in Alzheimer’s Disease

How Does Hyperphopsphorylation Promote Tau Aggregation and Modulate Filament Structure and Stability?

Regulation of Glycogen Synthase Kinase-3β by Phosphorylation and O-β-Linked N-Acetylglucosaminylation: Implications on Tau Protein Phosphorylation

Phosphorylation of Tau Antagonizes Apoptosis by Stabilizing Β-Catenin, a Mechanism Involved in Alzheimer's Neurodegeneration

Glycation alter the process of Tau phosphorylation to change Tau isoforms aggregation property

Uncovering the Effect of Ps202/pt205/ps208 Triple Phosphorylations on the Conformational Features of the Key Fragment G192-T212 of Tau Protein

Phosphorylation of Tau R2 Repeat Destabilizes Its Binding to Microtubules: A Molecular Dynamics Simulation Study

Hsp90 Maintains the Stability and Function of the Tau Phosphorylating Kinase GSK3β

Mis-regulation of GSK-3β causes axonal microtubule curling through Shot and Tau

O2-01-05

Human tau accumulation promotes glycogen synthase kinase-3β acetylation and thus upregulates the kinase: A vicious cycle in Alzheimer neurodegeneration

Phosphorylation and O-GlcNAcylation of the PHF-1 Epitope of Tau Protein Induce Local Conformational Changes of the C-Terminus and Modulate Tau Self-Assembly Into Fibrillar Aggregates

Tau Protein Antagonizes Cell Apoptosis Through Akt Pathway

Effects of Endogenous Β‐amyloid Overproduction on Tau Phosphorylation in Cell Culture

Effects of P301L-TAU on post-translational modifications of microtubules in human iPSC-derived cortical neurons and TAU transgenic mice

Overactivation of glycogen synthase kinase-3 by inhibition of phosphoinositol-3 kinase and protein kinase C leads to hyperphosphorylation of tau and impairment of spatial memory.

Modification of the Drosophila model of in vivo Tau toxicity reveals protective phosphorylation by GSK3β

Tau Phosphorylation by GSK3 in Different Conditions